UnitedHealth

INITIAL MARKET REACTION TO TRUMP VICTORY:

• U.S. Stocks: Broadly higher across sectors
• $XLF: Big banks higher on expectations of regulatory relief, M&A growth
• Cannabis Stocks: $WEED (+4,83%), $MSOS, $TLRY (+1,5%) down as Florida votes against legalization
• $CVS (+0,38%), $UNH (+0,52%) : Health insurers rally on potential easing of Medicare Advantage pressures
• $XLE (+1,63%) , $XOM (+2,02%): Energy stocks higher, anticipating fossil fuel support and less regulation
• Solar/Renewables: Pressure on $FSLR (+0,48%), $SEDG (-0,72%), EV, hydrogen, and battery stocks as clean energy subsidies could be rolled back
• Crypto: Higher as Trump holds a favorable stance, $BTC (+4,61%) strong
• $TSLA (+0,05%): Higher after Trump Win as Musk was all-in on support
• Bonds: Weaker, with yields rising on fiscal concerns
• China Stocks: Weak as tariff pressures and anti-China policy concerns grow
• Peso/Mexican Equities: Weaker on aggressive trade policies and tariffs fear
• FinTech: Higher with $HOOD (-0,51%), $AFRM (+4,86%) , $SQ (+4,3%), $SOFI (+6,03%) responding positively
• Dollar: Stronger due to pro-business policies
• $META (-0,73%), $SNAP (+0,6%): Mixed as TikTok ban concerns ease
• Overall: Dollar, crypto, energy, banks, and U.S. stocks higher; bonds, renewables, and cannabis under pressure.

Too good not to share with the GetQuin community, recent interview I did of a fellow dividend investor. Colby breaks down the necessity to understand your investor profile and timeline - something I typically harp on and why I sold $JNJ (+2,4%) for $UNH (+0,52%) while also shrugging off $SCHD for $VOO (+0,04%) and $VGT (+1,88%)

Let me now what you think, feel free to be as ruthless as you care to be!

https://youtu.be/8oLy-DFokCI

This upcoming week, I am most bullish on $UNH (+0,52%)
$MSFT (-0,01%) & $NKE (+3,24%) , 3 more made my list. What are you focused on this week?

https://www.youtube.com/watch?v=Hn_USzlBcUk

Looking for a phenomenal dividend GROWTH opportunity, you can now find it with UnitedHealth $UNH (+0,52%) - give it a look and let me know what you think!

$UNH (+0,52%) 's long-term EPS growth target of 13-16% is achievable, supported by the company's strong track record.

The stock looks reasonably priced right now, especially given the company's reliability and steady growth over the years.

Quanto potrà durare ancora questo Bull Market?

Com'è andata la trimestrale di UnitedHealth Group $UNH (+0,52%) ?

Ne parliamo nell'episodio di oggi!

https://youtu.be/UV_pZTq7bWY

$UNH (+0,52%) | UnitedHealth Group Q3'24 Earnings Highlights:

🔹 Adjusted EPS: $7.15 (Est. $6.99) 🟢

🔹 Revenue: $100.82B (Est. $99.16B) 🟢; UP +9% YoY

🔹 Medical Care Ratio: 85.2% (Prev. Year: 82.3%; Est. 84.4%) 😕

Guidance:

🔹 Narrows FY24 Adj EPS Forecast to $27.50 - $27.75 (Prev: $27.50 - $28.00) 🟡

Q3 Segment Performance:

🔹 UnitedHealthcare Revenue: $74.9B (Est. $73.65B) 🟢; UP +7% YoY

🔹 Optum Revenue: $63.9B; UP +13% YoY

— Optum Health Revenue: $25.9B; UP +9% YoY

— Optum Rx Revenue: $34.2B; UP +18% YoY

Other Q3 Metrics:

🔹 Net Income: $6.06B

🔹 Earnings from Operations: $8.71B

🔹 Operating Cost Ratio: 13.2% (Previous Year: 15.0%)

🔹 Cash Flows from Operations: $14B

Operational Highlights:

🔸 Consumers served by UnitedHealthcare’s commercial domestic offerings grew by 2.4 million year-to-date.

🔸 Cash flows from operations were $14.0B, or 2.2 times net income.

🔸 UnitedHealthcare serves 9.4 million seniors and people with complex needs; 2025 Medicare Advantage plans will reach 96% of eligible beneficiaries.

CEO Andrew Witty's Commentary:

🔸 "Our continued growth, which positions us well for the coming years, is rooted in the innovative products and responsive service of our people that are embraced each day across the full range of health care participants."

Additional Insights:

🔸 Adjusted earnings per share include $0.12 in business disruption impacts and exclude $0.28 in direct response costs related to a cyberattack.

🔸 The company did not have any favorable earnings impacting medical reserve development in the quarter.

🔸 Days Claims Payable: 47.4, compared to 45.2 in Q2 2024 and 50.7 in Q3 2023.

🔸 Return on Equity: 26.3% in the quarter.